Bio-Rad Announces CE IVD Marking of its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic

HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) announced CE IVD marking for its QX200™ Droplet Digital™ PCR (ddPCR™) System, the first digital PCR system with the CE IVD mark for use as an in vitro diagnostic (IVD) in the European Union. With the CE IVD mark, medical practitioners in Europe can use [...]

Luminex Corporation Announces Collaboration with University of Sao Paulo to Validate Zika Virus Detection Panel

AUSTIN, Texas, - Luminex Corporation (NASDAQ: LMNX) announced it is collaborating with the Laboratory of Molecular Evolution & Bioinformatics, Biomedical Sciences Institute, University of São Paulo, Brazil to validate a multi-analyte Zika virus assay developed by Luminex partner, GenArraytion, Inc. The MultiFLEX™ Mosquito-borne Panel is now available as a research use only (RUO) multiplex panel [...]

Matched ChIP-validated Antibodies & Primer Sets

Chromatrap announces that its high quality ChIP-validated antibodies can now be supplied with optimised matching primer sets. Using this out-of-box solution there is now no need to waste your valuable time searching databases and designing your own forward and reverse primers. Purchasing Chromatrap ChIP-validated antibodies with their matching high-quality primers, saves you time and gives [...]

ATCC® STANDARDS DEVELOPMENT ORGANIZATION RELEASES THIRD ANSI STANDARD

Manassas, VA, – ATCC, the premier global biological materials resource and standards organization, announces that the ATCC Standards Development Organization (SDO) completed and published the consensus standard: Species-Level Identification of Animal Cells through Mitochondrial Cytochrome c Oxidase Subunit 1 (CO1) DNA Barcodes (ANSI/ASN-0003-2015) for interspecies cell line identity based on sequence technology. This is the [...]

Thermo Fisher Scientific Declares Quarterly Dividend

WALTHAM, Mass. - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on April 15, 2016, to shareholders of record as of March 15, 2016. About Thermo Fisher Scientific Thermo Fisher [...]

Certara Introduces Phoenix Technology Services to Optimize Pharma R&D Productivity

PRINCETON, NJ - Certara®, the global biosimulation technology-enabled drug development company, announced the introduction of Phoenix® Technology Services. These services, led and implemented by Certara’s professional team of biosimulation (modeling and simulation) experts, include customized and ready-to-use solutions that span the breadth of the Phoenix platform. Phoenix is the industry’s premier software platform for managing, [...]

IntelliCyt and FIMM Announce a Collaboration to Advance Personalized Medicine in Cancer Treatment

Albuquerque, New Mexico - IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research today announced a collaboration with the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki to further the development of personalized medicine in cancer treatment. FIMM will utilize IntelliCyt products to test and [...]

Optofluidics Announces Major Updates for the NT Surface

Philadelphia, PA - Optofluidics, a Philadelphia-based nanotech startup, announced two upcoming features for their state-of-art nanoparticle analysis tool, the NT Surface, that will dramatically improve system ease of use and walk-away automation. Auto-Coupling The NT Surface will now ship with a robotic laser alignment system that automatically positions the laser, increasing system performance, reducing setup [...]

Director Declaration & Directorate Change

Oxford Instruments plc, a leading provider of high-technology tools and systems for industry and research, announces that it has been advised pursuant to Listing Rule 9.6.14(2) that Jock Lennox, Non-Executive Director has been appointed a Non-Executive Director of Barratt Developments plc, listed on the London Stock Exchange, with effect from 1 July 2016. The Company [...]

New 3D, 1000X magnification imaging modality for preclinical research

MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy – saving time and substantially reducing costs. MR Solutions, the world leader in preclinical scanning, [...]

Access IBO on Knowledge Center